Skip to main content

Research Repository

Advanced Search

Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein

Owsianka, Ania; Tarr, Alexander W.; Juttla, Vicky S.; Lavillette, Dimitri; Bartosch, Birke; Cosset, François Loïc; Ball, Jonathan K.; Patel, Arvind H.

Authors

Ania Owsianka

Vicky S. Juttla

Dimitri Lavillette

Birke Bartosch

François Loïc Cosset

Jonathan K. Ball

Arvind H. Patel



Abstract

Hepatitis C virus (HCV) remains a significant threat to the general health of the world's population, and there is a pressing need for the development of new treatments and preventative vaccines. Here, we describe the generation of retrovirus-based pseudoparticles (HCVpp) incorporating a panel of full-length E1E2 clones representative of the major genotypes 1 through 6, and their application to assess the reactivity and neutralizing capability of antisera and monoclonal antibodies raised against portions of the HCV E2 envelope protein. Rabbit antisera raised against either the first hypervariable region or ectodomain of E2 showed limited and strain specific neutralization. By contrast, the monoclonal antibody (MAb) AP33 demonstrated potent neutralization of infectivity against HCVpp carrying E1E2 representative of all genotypes tested. The concentration of AP33 required to achieve 50% inhibition of infection by HCVpp of diverse genotypes ranged from 0.6 to 32 μg/ml. The epitope recognized by MAb AP33 is linear and highly conserved across different genotypes of HCV. Thus, identification of a broadly neutralizing antibody that recognizes a linear epitope is likely to be of significant benefit to future vaccine and therapeutic antibody development. Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Citation

Owsianka, A., Tarr, A. W., Juttla, V. S., Lavillette, D., Bartosch, B., Cosset, F. L., Ball, J. K., & Patel, A. H. (2005). Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. Journal of Virology, 79(17), 11095-11104. https://doi.org/10.1128/JVI.79.17.11095-11104.2005

Journal Article Type Article
Acceptance Date Jun 1, 2005
Online Publication Date Sep 1, 2005
Publication Date Sep 1, 2005
Deposit Date Nov 9, 2022
Journal Journal of Virology
Print ISSN 0022-538X
Electronic ISSN 1098-5514
Publisher American Society for Microbiology
Peer Reviewed Peer Reviewed
Volume 79
Issue 17
Pages 11095-11104
DOI https://doi.org/10.1128/JVI.79.17.11095-11104.2005
Public URL https://nottingham-repository.worktribe.com/output/3129655
Publisher URL https://journals.asm.org/doi/10.1128/JVI.79.17.11095-11104.2005